Optimizing RSV Vaccine Trials for a Healthier Tomorrow

Vaccine trials, especially for RSV, present unique challenges, from large-scale logistics to long-term patient follow-up.

We provide proven solutions to optimize your trial’s success. Our SmartSignals platform integrates eCOA, RTSM, eConsent, telemedicine, and patient concierge services to streamline data collection, improve engagement, and ensure regulatory compliance.

With over 80,500 patients across 37 countries, we bring decades of experience and global reach to accelerate your vaccine trials, delivering high-quality, audit-ready evidence to support regulatory approval.